Gilead Sciences, Inc. GILD NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - General • US • USD

SharesGrow Score

78/100

6/7 Pass

SharesGrow Intrinsic Value

Gilead Sciences, Inc. (GILD) 报告总资产为 $59.02B 总负债为 $36.41B 財年 2025, 总权益为 $22.62B.

公司持有 $10.61B 现金及短期投资. 总债务为 $24.59B, 净债务为 $17.03B. D/E比率为 1.09 (适中的).

流动比率为 1.68, 表明短期流动性强. 利息覆蓋率为 11.5x (强劲的).

本页支持的标准:

HEALTH (83/100, Pass) — Debt-to-Equity of 1.09, current ratio of 1.68, interest coverage 11.5x — 资产负债表强劲
MOAT (90/100) — 总资产 $59.02B 和 equity $22.62B 支持公司的竞争规模
VALUE (57/100) — Debt-to-Equity 1.09 影响整体估值风险评估

SharesGrow 收入评分: 78/100 其中 6/7 项标准通过.

SharesGrow 7-Criteria Score

78/100

SG Score

View full scorecard →

价值

57/100

Price-to-Earnings & upside

→ Valuation

✓

未來

61/100

Analyst consensus

→ Forecast

✓

过去

100/100

→ Income

✓

健康

83/100

Debt-to-Equity & liquidity

Proven by this page

✓

护城河

90/100

→ Income

✓

成长

73/100

→ Income

✓

收入

85/100

→ Income

Gilead Sciences, Inc. 资产负债表历史

指标	FY2025	FY2024	FY2023	FY2022
总资产	$59.02B	$59B	$62.13B	$63.17B
Total Liabilities	$36.41B	$39.75B	$39.38B	$41.96B
总债务	$24.59B	$26.71B	$24.99B	$25.23B
Cash & Investments	$10.61B	$11.57B	$7.26B	$6.39B
股东权益总计	$22.62B	$19.33B	$22.83B	$21.24B